These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31087053)

  • 21. [Plasma aldosterone levels in primary aldosteronism. 1. Renin-angiotensin system and aldosterone].
    Fukuchi S; Takenouchi T; Nakajima K
    Nihon Naibunpi Gakkai Zasshi; 1973 May; 49(5):781-7. PubMed ID: 4353260
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.
    Fukuda N; Soma M; Kubo A; Kunimoto M; Watanabe Y; Izumi Y; Kanmatsuse K
    J Endocrinol Invest; 1997 Jan; 20(1):13-7. PubMed ID: 9075066
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
    Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
    Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of the serotonin 5-HT4 receptor agonist cisapride on aldosterone secretion in corticotropic insufficiency and primary hyperaldosteronism.
    Lefebvre H; Dhib M; Godin M; Contesse V; Delarue C; Rieu M; Wolf LM; Vaudry H; Kuhn JM
    Neuroendocrinology; 1997 Sep; 66(3):229-33. PubMed ID: 9380281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects.
    Lachurié ML; Azizi M; Guyene TT; Alhenc-Gelas F; Ménard J
    Circulation; 1995 Jun; 91(12):2933-42. PubMed ID: 7796503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelin receptor blockade lowers plasma aldosterone levels via different mechanisms in primary aldosteronism and high-to-normal renin hypertension.
    Rossi GP; Ganzaroli C; Cesari M; Maresca A; Plebani M; Nussdorfer GG; Pessina AC
    Cardiovasc Res; 2003 Jan; 57(1):277-83. PubMed ID: 12504838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenal steroid responses to ACTH in glucocorticoid-suppressible aldosteronism.
    Ganguly A; Weinberger MH; Guthrie GP; Fineberg NS
    Hypertension; 1984; 6(4):563-7. PubMed ID: 6086520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of aldosterone secretion in primary aldosteronism.
    Spark RF; Dale SL; Kahn PC; Melby JC
    J Clin Invest; 1969 Jan; 48(1):96-104. PubMed ID: 4303791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemodynamic and biochemical consequences of renin inhibition by infusion of CGP 38560A in normal volunteers.
    Nussberger J; Delabays A; De Gasparo M; Cumin F; Waeber B; Brunner HR; Ménard J
    Hypertension; 1989 Jun; 13(6 Pt 2):948-53. PubMed ID: 2661435
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
    Tomaschitz A; Piecha G; Ritz E; Meinitzer A; Haas J; Pieske B; Wiecek A; Rus-Machan J; Toplak H; März W; Verheyen N; Gaksch M; Amrein K; Kraigher-Krainer E; Fahrleitner-Pammer A; Pilz S
    Clin Exp Hypertens; 2015; 37(2):108-15. PubMed ID: 24785704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic outcome of primary aldosteronism: adrenalectomy versus enucleation of aldosterone-producing adenoma.
    Nakada T; Kubota Y; Sasagawa I; Yagisawa T; Watanabe M; Ishigooka M
    J Urol; 1995 Jun; 153(6):1775-80. PubMed ID: 7752314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
    J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term effects of olmesartan, an Ang II receptor antagonist, on blood pressure and the renin-angiotensin-aldosterone system in hypertensive patients.
    Ichikawa S; Takayama Y
    Hypertens Res; 2001 Nov; 24(6):641-6. PubMed ID: 11768722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy.
    Brandt C; Hillmann P; Noack A; Römermann K; Öhler LA; Rageot D; Beaufils F; Melone A; Sele AM; Wymann MP; Fabbro D; Löscher W
    Neuropharmacology; 2018 Sep; 140():107-120. PubMed ID: 30081001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A delayed suppression of the renin-aldosterone axis following saline infusion in human hypertension.
    Tuck ML; Williams GH; Dluhy RG; Greenfield M; Moore TJ
    Circ Res; 1976 Nov; 39(5):711-7. PubMed ID: 975459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of an angiotensin II receptor antagonist in managing hyperaldosteronism.
    Stokes GS; Monaghan JC; Ryan M; Woodward M
    J Hypertens; 2001 Jun; 19(6):1161-5. PubMed ID: 11403366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
    Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
    Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile.
    Shibata H; Suzuki H; Murakami M; Sato A; Saruta T
    J Hypertens; 1994 Nov; 12(11):1275-84. PubMed ID: 7868875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The application of captopril challenge test in the diagnosis of primary aldosteronism].
    Chen S; Zeng ZP; Song AL; Zhu L; Lu L; Tong AL; Shi C; Li HZ
    Zhonghua Nei Ke Za Zhi; 2017 Jun; 56(6):402-408. PubMed ID: 28592038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.